AIMS: In east-Asian countries, while almost all Helicobacter pylori strains possess the cytotokine-associated gene A (CagA) gene, serum CagA antibody is not detected in some infected subjects. We aimed to clarify the association between anti-CagA antibody and gastric cancer in east-Asian countries. MATERIALS AND METHODS: We performed a meta-analysis of case-control studies with age- and sex-matched controls, which provided raw data in east-Asian countries. RESULTS: Ten studies with a total of 4325 patients were identified in the search. Some reports from Japan, Korea and China showed a positive association between the presence of anti-CagA antibody and gastric cancer; however, the results differed in their various backgrounds. The disparate findings appeared to result from the use of different methods or from variations in the antigens used to detect the anti-CagA antibody. CagA seropositivity was associated with an increased risk of developing gastric cancer. CONCLUSION: Anti-CagA antibody can be used as a biomarker for gastric cancer even in east-Asian countries.
AIMS: In east-Asian countries, while almost all Helicobacter pylori strains possess the cytotokine-associated gene A (CagA) gene, serum CagA antibody is not detected in some infected subjects. We aimed to clarify the association between anti-CagA antibody and gastric cancer in east-Asian countries. MATERIALS AND METHODS: We performed a meta-analysis of case-control studies with age- and sex-matched controls, which provided raw data in east-Asian countries. RESULTS: Ten studies with a total of 4325 patients were identified in the search. Some reports from Japan, Korea and China showed a positive association between the presence of anti-CagA antibody and gastric cancer; however, the results differed in their various backgrounds. The disparate findings appeared to result from the use of different methods or from variations in the antigens used to detect the anti-CagA antibody. CagA seropositivity was associated with an increased risk of developing gastric cancer. CONCLUSION: Anti-CagA antibody can be used as a biomarker for gastric cancer even in east-Asian countries.
Authors: Chang-Young Park; Yong-Kyun Cho; Tadashi Kodama; Hala M T El-Zimaity; Michael S Osato; David Y Graham; Yoshio Yamaoka Journal: J Clin Microbiol Date: 2002-12 Impact factor: 5.948
Authors: Roberto Stasi; Ameet Sarpatwari; Jodi B Segal; John Osborn; Maria Laura Evangelista; Nichola Cooper; Drew Provan; Adrian Newland; Sergio Amadori; James B Bussel Journal: Blood Date: 2008-10-22 Impact factor: 22.113
Authors: Richard H Argent; Mark Kidd; Robert J Owen; Rachael J Thomas; Marie C Limb; John C Atherton Journal: Gastroenterology Date: 2004-08 Impact factor: 22.682
Authors: Paula Delgado; Natalia Peñaranda; María Antonia Zamora; María del Pilar Delgado; Eliana Bohorquez; Harold Castro; Andrés Fernando González Barrios; Carlos Jaramillo Journal: J Mol Model Date: 2014-08-14 Impact factor: 1.810